Vascular Angiotensin-Converting Enzyme 2: Lord of the Ring?

Circulation Research- United States

doi 10.1161/circresaha.110.229831

Full Text

Abstract

Available in

Date

Authors

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Murine Recombinant Angiotensin-Converting Enzyme 2: Effect on Angiotensin II-Dependent Hypertension and Distinctive Angiotensin-Converting Enzyme 2 Inhibitor Characteristics on Rodent and Human Angiotensin-Converting Enzyme 2

Hypertension
Internal Medicine
2012English

Angiotensin Converting Enzyme

English

Angiotensin Converting Enzyme

English

Angiotensin Converting Enzyme

English

Angiotensin-Converting Enzyme 2 (ACE2) in Disease Pathogenesis

Circulation Journal
MedicineCardiovascular MedicineCardiology
2010English

Renin Inhibitor and Converting Enzyme Inhibitors Suppress Vascular Angiotensin II.

Hypertension
Internal Medicine
1989English

Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Angiotensin-Converting Enzyme 2 and Treatment With Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Type 1 Receptor Blockers

European Journal of Preventive Cardiology
EpidemiologyCardiovascular MedicineCardiology
2020English

The Relationship of Angiotensin I Converting Enzyme Gene I/D Polymorphism and Angiotensin Converting Enzyme 2 Gene A9570G Polymorphism With Atrial Fibrillation

Heart
Cardiovascular MedicineCardiology
2011English

Signaling by the Angiotensin-Converting Enzyme

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy